Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: a WhatsApp messenger-based report from the Italian College of Chief Medical Oncologists.

COVID-19 outbreak WhatsApp messenger action taken medical oncologists reactions sentimental analysis

Journal

Ecancermedicalscience
ISSN: 1754-6605
Titre abrégé: Ecancermedicalscience
Pays: England
ID NLM: 101392236

Informations de publication

Date de publication:
2020
Historique:
received: 23 04 2020
entrez: 23 6 2020
pubmed: 23 6 2020
medline: 23 6 2020
Statut: epublish

Résumé

This descriptive, unplanned investigation has been undertaken to report reactions, attitudes and countermeasures which have been put in place and implemented by medical oncology units facing the COVID-19 outbreak in Southern Italy. Data have been retrospectively obtained from the time-related analysis of conversations via a WhatsApp messenger-based group chat between the medical directors belonging to the Italian College of Medical Oncology Directors. Overall number, intensity and time trend of conversations related to reactions during the 4 weeks of observation related to the crucial events which occurred between 24 February and 28 March, 2020 2020 are included. A sentiment analysis of conversations was also carried out. We report 956 conversations among 19 medical oncology units related to reactions to the crucial events, such as epidemic spread, Government ordinances and guidelines during the 4 weeks of observation. Data show significant awareness of problems linked to the COVID-19 spread among oncologists and rapid diffusion of countermeasures. Actions taken were correlated time wise to crucial events. A correlation between conversations and the volume of activity of oncology units was found. By analysing the sentiment analysis of raw data, positive emotions were reduced in percentage over the weeks. A significant increase in negative emotions was observed as the outbreak impacted on the healthcare system. In our experience, the WhatsApp instant-messaging system seems to be a useful tool to share news and reactions between medical oncologists to rapidly implement necessary health measures and answers to most cancer patients' needs and queries in the COVID-19 pandemic scenario.

Sections du résumé

BACKGROUND BACKGROUND
This descriptive, unplanned investigation has been undertaken to report reactions, attitudes and countermeasures which have been put in place and implemented by medical oncology units facing the COVID-19 outbreak in Southern Italy.
MATERIALS AND METHODS METHODS
Data have been retrospectively obtained from the time-related analysis of conversations via a WhatsApp messenger-based group chat between the medical directors belonging to the Italian College of Medical Oncology Directors. Overall number, intensity and time trend of conversations related to reactions during the 4 weeks of observation related to the crucial events which occurred between 24 February and 28 March, 2020 2020 are included. A sentiment analysis of conversations was also carried out.
RESULTS RESULTS
We report 956 conversations among 19 medical oncology units related to reactions to the crucial events, such as epidemic spread, Government ordinances and guidelines during the 4 weeks of observation. Data show significant awareness of problems linked to the COVID-19 spread among oncologists and rapid diffusion of countermeasures. Actions taken were correlated time wise to crucial events. A correlation between conversations and the volume of activity of oncology units was found. By analysing the sentiment analysis of raw data, positive emotions were reduced in percentage over the weeks. A significant increase in negative emotions was observed as the outbreak impacted on the healthcare system.
CONCLUSION CONCLUSIONS
In our experience, the WhatsApp instant-messaging system seems to be a useful tool to share news and reactions between medical oncologists to rapidly implement necessary health measures and answers to most cancer patients' needs and queries in the COVID-19 pandemic scenario.

Identifiants

pubmed: 32565899
doi: 10.3332/ecancer.2020.1046
pii: can-14-1046
pmc: PMC7289620
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1046

Informations de copyright

© the authors; licensee ecancermedicalscience.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to declare. Dario Piazza (project and data analyst manager), Alberto Firenze (epidemiologist), Michele Caruso, Massimiliano Spada, and Dario Giuffrida (medical oncologists), do not belong to the CIPOMO but they are allowed to participate. Vittorio Gebbia, as a professor of medical oncology, is, however, part of the mailing list and allowed to participate in CIPOMO-bases activities.

Références

JAMA. 2020 Mar 13;:
pubmed: 32167538
JAMA. 2020 Mar 23;:
pubmed: 32203977
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Lancet Oncol. 2020 Apr;21(4):e181
pubmed: 32142621
PLoS One. 2019 Jan 11;14(1):e0209873
pubmed: 30633754
JAMA Netw Open. 2020 Feb 5;3(2):e200001
pubmed: 32101302
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
J Int Med Res. 2009 Sep-Oct;37(5):1543-51
pubmed: 19930862
J Diabetes Sci Technol. 2019 May;13(3):439-444
pubmed: 30453762
Stud Health Technol Inform. 2020 Mar 2;268:123-138
pubmed: 32141884
J Med Internet Res. 2016 Jun 16;18(6):e120
pubmed: 27311444
Int J Med Inform. 2017 Jan;97:145-151
pubmed: 27919374
J Natl Compr Canc Netw. 2020 Mar 20;:1-4
pubmed: 32197238
Acta Neuropsychiatr. 1997 Jun;9(2):58-60
pubmed: 26972127
Int J Med Inform. 2018 Dec;120:92-100
pubmed: 30409350
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Front Psychol. 2017 Jun 02;8:796
pubmed: 28626431
JAMA Oncol. 2020 Mar 25;:
pubmed: 32211820
J Med Internet Res. 2013 Nov 01;15(11):e239
pubmed: 24184993
Patient Educ Couns. 2017 Feb;100(2):183-189
pubmed: 27595436
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Telemed J E Health. 2020 Feb 21;:
pubmed: 32083515
Endosc Int Open. 2019 Aug;7(8):E1027-E1030
pubmed: 31404419
Stud Health Technol Inform. 2016;231:82-90
pubmed: 27782019

Auteurs

Livio Blasi (L)

Medical Oncology Unit, Arnas, Ospedale Civico, Palermo, 90100, and National President of CIPOMO, Italy.

Roberto Bordonaro (R)

Medical Oncology Unit, Arnas, Ospedale Garibaldi, Catania, 95100, Italy.

Nicolò Borsellino (N)

Medical Oncology Unit, Ospedale Buccheri La Ferla, Palermo, 90100, Italy.

Alfredo Butera (A)

Medical Oncology Unit, Ospedale San Giovanni di Dio, Agrigento, 92100, Italy.

Michele Caruso (M)

Medical Oncology Unit, Istituto Clinico Humanitas, Catania, 95100, Italy.

Stefano Cordio (S)

Medical Oncology Unit, Ospedale Paterno Arezzo, Ragusa, 97100, Italy.

Di Cristina Liborio (DC)

Medical Oncology Unit, Ospedale Vittorio Emanuele, Castelvetrano, 91022, Italy.

Francesco Ferraù (F)

Medical Oncology Unit, Ospedale San Vincenzo, Taormina, 98039, Italy.

Dario Giuffrida (D)

Medical Oncology Unit, Istituto Oncologico Mediterraneo, Viagrande, 95029, Italy.

Hector Soto Parra (HS)

Medical Oncology Unit, Policlinico, Catania, 95100, Italy.

Massimiliano Spada (M)

Medical Oncology Unit, Ospedale Giglio, Cefalù, 90015, Italy.

Paolo Tralongo (P)

Medical Oncology Unit, Ospedale Umberto I, Siracusa, 96100, Italy.

Roberto Valenza (R)

Medical Oncology Unit, Ospedale Vittorio Emanuele, Gela, 93012, Italy.

Francesco Verderame (F)

Medical Oncology Unit, Ospedale Cervello-Villa Sofia, Palermo, 90100, Italy.

Stefano Vitello (S)

Medical Oncology Unit, Ospedale Sant'Elia, Caltanissetta, 93100, Italy.

Filippo Zerilli (F)

Medical Oncology Unit, Ospedale San Antonio Abate, Trapani, 91100, Italy.

Dario Piazza (D)

GSTU Foundation, Palermo, 90100, Italy.

Alberto Firenze (A)

Risk Management Unit, Policlinico, Palermo, 90100, Italy.

Vittorio Gebbia (V)

Medical Oncology Unit, Ospedale La Maddalena, University of Palermo, Palermo, 90100, Italy.

Classifications MeSH